| ||||||||||||||||||||||||||||
Augmentation Therapy |
What is augmentation therapy? Augmentation therapy is the administration of an IV infused protease inhibitor to replace the antitrypsin the ZZ patient doesn't have circulating in their bloodstream. Patients generally receive the infusions on a weekly basis, though some patients arrange for bi-weekly or monthly infusions. The object of augmentation therapy is to maintain an Alpha level of therapeutic levels. The recommended dosage is 60 mg/kg. How do I qualify for infusion therapy? Your doctor must write a prescription and make the arrangement for augmentation therapy. There are restrictions: These guidelines are normally followed by most insurance companies. In addition, the American Thoracic Society recommends initial screening for HIV and that the patient be administered Hepititis B vaccinations. They also suggest liver function tests to rule out liver involvement. The use of augmentation therapy is not indicated for patients with liver disease. Who do I contact for these infusions? Depending on your medical insurance coverage, your doctor will decide which augmentation therapy is best for you. Currently there are three products available and depending on your insurance, you may be able to receive the infusions at home. If you have Medicare or Medicaid and are not designated homebound, you will be required to have your infusions at your doctor's office (if they provide this service) or at a hospital infusion center. Patients can also self-infuse. This involves being taught how to mix the medication and then hook themselves up to the IV line. Some patients choose to have a port placed in their arm or upper chest area so that they do not have to do a needle stick weekly. If your insurance covers home infusions, you will have a nurse come to your home to mix your medication, take your vital statistics (blood pressure, temp, etc.), write a report to your doctor and then complete the infusion. What are the three therapies available? Aralast: For complete information about Aralast including information for patients and health professionals, go to: http://www.aralast.com/patients_families/index.html Whether you are newly diagnosed with alpha1-antitrypsin (AAT) deficiency or are a long-time Alpha-1 patient, there’s useful information there for you. A prescription must be written by your doctor. Prolastin: From their web site: http://www.prolastin.com Talecris Biotherapeutics is a worldwide healthcare company. Talecris Biotherapeutics acquired the contributed assets of the worldwide plasma business of Bayer Biological Products and became operational April 1, 2005. All plasma-based products - including Gamunex, Prolastin, the hyperimmune line (Fraction II), Plasbumin (Bayer Albumin), Koate DVI and Thrombate III - related facilities, and employees are now functioning under the name Talecris Biotherapeutics. For more information about Talecris Biotherapeutics, please contact your local Biological Account Executive, Customer Service at 1-800-243-4153. Once again, a prescription must be written by your doctor. Zemaira: Distributed exclusively by Accredo to US patients only. Information about Zemaira can be seen at : http://www.zemaira.com Accredo Therapeutics 1640 Century Center Parkway, Suite 105 Memphis, TN 38134 1-866-6ALPHA1 (866-625-7421) http://www.accredotx.com A prescription is required from your doctor.
Return Home | Return to Education Resources | Return to Informational Resources Telephone: 540-948-6777 or 1-866-FOR-A1AA (1-866-367-2122) Fax # 540-948-6763 Copyright © 2006 Alpha-1 Advocacy Alliance, All Rights Reserved Home | Disclaimer | Privacy Policy | |||||||||||||||||||||||||||